Y-mabs Therapeutics, Inc.
YMAB
Revenue
19.53M
▼-1.38M▼-6.60%
3 Months ChangeAssets
117.21M
▲4.60M▲4.08%
3 Months ChangeLiabilities
29.72M
▲6.56M▲28.34%
3 Months ChangeFree Cash Flow
-7.04M
▲25.22M▲78.18%
48 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-09-20
Form 8-K
ID: 0001558370-24-012925
2024-09-17
Form 8-K
ID: 0001558370-24-012850
2024-08-12
Form 10-Q
ID: 0001558370-24-011795
2024-08-12
Form 8-K
ID: 0001558370-24-011792
2024-07-19
Form 8-K
ID: 0001558370-24-009915
2024-07-01
Form 8-K
ID: 0001558370-24-009643
2024-06-28
Form 8-K
ID: 0001558370-24-009614
2024-06-13
Form 8-K
ID: 0001104659-24-071250
2024-05-07
Form 10-Q
ID: 0001558370-24-007056
2024-05-07
Form 8-K
ID: 0001558370-24-007047